These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10501653)

  • 1. Diabetes and the role of inositol-containing lipids in insulin signaling.
    Jones DR; Varela-Nieto I
    Mol Med; 1999 Aug; 5(8):505-14. PubMed ID: 10501653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
    Farese RV; Standaert ML; Yamada K; Huang LC; Zhang C; Cooper DR; Wang Z; Yang Y; Suzuki S; Toyota T
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11040-4. PubMed ID: 7972005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glycosyl-phosphoinositides in hormone action.
    Saltiel AR
    J Bioenerg Biomembr; 1991 Feb; 23(1):29-41. PubMed ID: 1849135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of a second messenger for insulin.
    Saltiel AR; Cuatrecasas P
    Am J Physiol; 1988 Jul; 255(1 Pt 1):C1-11. PubMed ID: 2839033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin mediators in man: effects of glucose ingestion and insulin resistance.
    Shashkin PN; Shashkina EF; Fernqvist-Forbes E; Zhou YP; Grill V; Katz A
    Diabetologia; 1997 May; 40(5):557-63. PubMed ID: 9165224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway.
    Gao YF; Zhang MN; Wang TX; Wu TC; Ai RD; Zhang ZS
    Mol Cell Endocrinol; 2016 Sep; 433():26-34. PubMed ID: 27212205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ; Iuorno MJ
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1295-8. PubMed ID: 11117673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosyl-phosphatidylinositol/inositol phosphoglycan: a signaling system for the low-affinity nerve growth factor receptor.
    Represa J; Avila MA; Miner C; Giraldez F; Romero G; Clemente R; Mato JM; Varela-Nieto I
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8016-9. PubMed ID: 1654553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.
    Aytug S; Reich D; Sapiro LE; Bernstein D; Begum N
    Hepatology; 2003 Dec; 38(6):1384-92. PubMed ID: 14647049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsia.
    Scioscia M; Nigro M; Montagnani M
    J Reprod Immunol; 2014 Mar; 101-102():140-147. PubMed ID: 23962711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.
    Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW
    J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.
    Scioscia M; Gumaa K; Kunjara S; Paine MA; Selvaggi LE; Rodeck CH; Rademacher TW
    J Clin Endocrinol Metab; 2006 Feb; 91(2):709-17. PubMed ID: 16332940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
    Tzatsos A; Kandror KV
    Mol Cell Biol; 2006 Jan; 26(1):63-76. PubMed ID: 16354680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
    Elased KM; Gumaa KA; de Souza JB; Rahmoune H; Playfair JH; Rademacher TW
    Mol Genet Metab; 2001 Jul; 73(3):248-58. PubMed ID: 11461192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.
    Whitman M; Downes CP; Keeler M; Keller T; Cantley L
    Nature; 1988 Apr; 332(6165):644-6. PubMed ID: 2833705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular Mechanisms of Insulin Resistance: An Update].
    Gutiérrez-Rodelo C; Roura-Guiberna A; Olivares-Reyes JA
    Gac Med Mex; 2017; 153(2):214-228. PubMed ID: 28474708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.